The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ARICEPT



Imbat LimitedPPA1151/037/002

Main Information

Trade NameARICEPT
Active SubstancesDONEPEZIL HYDROCHLORIDE
Dosage FormFilm Coated Tablet
Licence HolderImbat Limited
Licence NumberPPA1151/037/002

Group Information

ATC CodeN06DA02 donepezil

Status

License statusWithdrawn
Withdrawn Date27/09/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back